Phytocannabinoid scientists unveils lozenge to treat H1N1 swine flu and H5N1 bird flu

World Health Organization has just declared a swine flu pandemic - raising its pandemic warning from phase 5 to 6.

This is the first global flu epidemic in 41 years. There have been outbreaks in Asia, the Middle East and Europe.

Dr. Robert J. Melamede, Director and Chief Science Officer for Cannibis Science Inc. reports, "Research into use of whole cannabis extracts and multi-cannabinoid compounds has provided the scientific rationale for medical marijuana’s efficacy in treating some of the most troubling diseases mankind now faces, including infectious diseases such as the flu and HIV, autoimmune diseases such as ALS (Lou Gehrig’s Disease), multiple sclerosis, arthritis, and diabetes, neurological conditions such as Alzheimer's, stroke and brain injury, as well as numerous forms of cancer."

Dr. Melamede went on to say, "The high lethality of some strains of flu can be attributed to the excessive inflammatory response driven by Tumor Necrosis Factor (TNF). Endocannabinoids are nature’s way of controlling TNF activity. Phytocannabinoids can mimic the natural endocannabinoids to prevent excessive inflammatory immune responses."

Cannabis Science Inc., President & CEO, Steven W. Kubby sent a letter to Homeland Security Administration Secretary Janet Napolitano.   "We have the science and preliminary anecdotal results confirming the anti-inflammatory properties of our new lozenges and indicating they may present an effective and non-toxic treatment for minimizing the symptoms and harm from influenza infections. Our lozenges appear to down-regulate the body's excessive inflammatory response to the influenza virus, which could reduce the deadly consequences of an infection into something that is more like a common cold. Because of my cancer and diminished auto-immune functions, even common influenza is a deadly threat, and I've had incredible symptomatic relief with the lozenge."

Chief Science Officer for CSI Dr. Melamede believes the potential for cannabinoids that naturally prevent excessive inflammatory immune responses is enormous. He stated, "Based upon recent discoveries regarding the role that endocannabinoid system plays in maintaining human health, we may have a unique solution to the looming threat posed by deadly influenza strains that we believe, if implemented, could save millions of lives."

Dr. Robert J. Melamede, Director and Chief Science Officer, stated, "The influenza virus has a unique genetic make up that, in combination with its replicative machinery, has an extraordinary capacity to mutate. As a result, the high lethality of some strains can be attributed to the resulting adult respiratory distress syndrome (ARDS). ARDS is caused by an excessive immune inflammatory response driven by Tumor Necrosis Factor (TNF) that leads to the death of respiratory epithelial cells and resulting organ failure. Endocannabinoids are nature's way of controlling TNF activity. Existing peer reviewed publications have shown that phytocannabinoids can prevent this cell death by mimicking the endocannabinoids that nature has selected to prevent excessive inflammatory immune responses." 

Cannabis Revolution Examiner

Cannabis Science Inc. - Endocannabinoid deficiency causes aging

Cannabis Science Inc. CBIS  - Is this stock a good investment?

Post-influenza psychosis in past pandemics - Cannabis Science Inc. lozenges to the rescue